Molecular Partners Ag (MOLN) Net Income towards Common Stockholders (2021 - 2025)
Historic Net Income towards Common Stockholders for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to -$15.1 billion.
- Molecular Partners Ag's Net Income towards Common Stockholders fell 11505936388.39% to -$15.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.0 billion, marking a year-over-year decrease of 2410271665.74%. This contributed to the annual value of -$61.4 million for FY2024, which is 1208.85% up from last year.
- Per Molecular Partners Ag's latest filing, its Net Income towards Common Stockholders stood at -$15.1 billion for Q3 2025, which was down 11505936388.39% from $4.7 million recorded in Q2 2025.
- Molecular Partners Ag's 5-year Net Income towards Common Stockholders high stood at $165.2 billion for Q1 2022, and its period low was -$16.3 billion during Q1 2023.
- In the last 5 years, Molecular Partners Ag's Net Income towards Common Stockholders had a median value of -$17253.2 in 2025 and averaged $6.3 billion.
- Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first surged by 90218183697.23% in 2022, then tumbled by 11505936388.39% in 2025.
- Molecular Partners Ag's Net Income towards Common Stockholders (Quarter) stood at -$68.7 million in 2021, then soared by 277.85% to $122.2 million in 2022, then crashed by 100.77% to -$939914.8 in 2023, then surged by 977.59% to $8.2 million in 2024, then crashed by 182641.67% to -$15.1 billion in 2025.
- Its last three reported values are -$15.1 billion in Q3 2025, $4.7 million for Q2 2025, and -$17253.2 during Q1 2025.